Press Releases

XORTX Provides Update on FDA Type B Meeting Request

XORTX Announces Grant of European Patent

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

XORTX Announces Update for Discussion with the FDA

XORTX Commences Gout Program NDA Discussions with the FDA

XORTX to Present at Microcap Conference

XORTX Announces Change of Auditor

XORTX Adds Late Stage Gout Program to Pipeline

XORTX Strengthens Executive Team

XORTX Announces Presentation at the Rare and Genetic Disease Summit